PATENT CLAIM ANALYSIS

Application Number: 16175220
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "094300"]

Abstract:
Disclosed are new small molecules having a substituted quinazoline core structure and the uses thereof for modulating glucocerebrosidase activity. Also disclosed are pharmaceutical compositions comprising the small molecules or activated glucocerebrosidase conjugated to the small molecules, which compositions may be administered in methods of treating diseases or disorders associated with glucocerebrosidase activity, including neurological diseases and disorders such as Gaucher's disease and Parkinson's disease.

Claim (Index 19):
A pharmaceutical composition comprising the activated glucocerebrosidase of  claim 18  and a pharmaceutical carrier.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15199207', '16021972', '15199220', '15789645', '10988428']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7137922685913697
- 35 USC 102 Novelty (BERT): 0.5623605604449716
- Combined Prediction Score: 0.6986490977767299
- Mean Citation Score: 340.0264140000001
- Max Citation Score: 457.09766
- Similarity Product: 316.5885692358017

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test